Neurostimulation Devices Market Analysis

  • Report ID: 4239
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Neurostimulation Devices Market Segmentation:

End-user 

The hospitals segment is anticipated to garner the largest market share over the forecast period, owing to the rising healthcare infrastructure globally, and the increasing incidence of chronic pain. As per the data, Indian healthcare infrastructure is projected to grow to USD 345 billion by the end of 2022. In addition, the growing number of hospitals globally is also expected to boost the growth of this segment in the coming years. 

Product

The spinal cord stimulation segment is anticipated to lead the market in terms of revenue. Some of the factors influencing the growth of this market include the rising prevalence of spinal cord injuries, chronic pain, the rising acceptance of SCS devices, and the attractive reimbursement environment for SCS treatments. As per data, more than 16,900 new cases of spinal cord injuries occur in the United States every year.

Our in-depth analysis of the global market includes the following segments:

         By Product Type

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Cochlear Implants
  • Vagus Nerve Stimulators
  • Sacral Nerve Stimulators
  • Percutaneous Tibial Nerve Stimulators
  • Transcranial Magnetic Stimulators

        By Application

  • Chronic Pain
  • Movement Disorders
  • Hearing Impairment
  • Epilepsy
  • Urinary Incontinence
  • Others

        By End-user

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of neurostimulation devices is assessed at USD 9.13 billion.

The global neurostimulation devices market size was valued at over USD 8.23 billion in 2025 and is expected to expand at a CAGR of around 12.2%, surpassing USD 26.02 billion revenue by 2035.

North America’s neurostimulation devices market dominates with a 58.7% share by 2035, driven by rising prevalence of neurological disorders, a growing geriatric population, and increasing adoption of implantable neurostimulation devices.

Key players in the market include Abbott Laboratories, Boston Scientific Corporation, Integer Holdings Corporation, Medtronic, Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Synapse Biomedical Inc., Soterix Medical, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos